Clinical Trial: Sleep Disorders of Patients with Diseases of the Nervous System

This study is currently recruiting patients.

Sponsored by: National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: Warren G Magnuson Clinical Center (CC)

Purpose

The purpose of this study is to assist training doctors about different diseases of the nervous system affecting sleep.

Patients selected to participate in this study will have any of a variety of sleep disorders. They will undergo several tests including an overnight recording of brain activity, eye movement, leg movement, breathing, heart rate, and other measures.

Results of these tests will be used to better understand diseases causing sleep disorders and may be used to develop better treatments for them.

Condition Treatment or Intervention
Hypersomnia
Narcolepsy
Nervous System Disease
Sleep Disorder
 Procedure: Sleep study

MedlinePlus related topics:  Neurologic Diseases;   Sleep Disorders

Study Type: Interventional
Study Design: Training

Official Title: Training Protocol for Various Sleep Disorders in Patients with Neurological Disorders

Further Study Details: 

Expected Total Enrollment:  80

Study start: December 4, 1996

The objective of this protocol is to provide training in a broad range of neurological sleep disorders to clinical associates who are eligible for sitting in the Board examination of the Added Qualification of Clinical Neurophysiology administered by the American Board of Psychiatry and Neurology. This protocol is to supplement small accrual of research patients who are referred from within the NIH.

Eligibility

Genders Eligible for Study:  Both

Criteria

IINCLUSION CRITERIA:
Patients 5 years of age and older, with the following referring diagnoses:
Narcolepsy
Hypersomnia
REM behavior disorder
Frontal nocturnal dystonia
Restless legs syndrome
Insomnia
Parasomnia
Nocturnal epileptic seizure
Nocturnal movement disorder
Sleep-related diagnostic dilemma
Sleep apnea associated with neurological disorders
Patients who are ambulatory and who are able to comply with the study procedures.
Patients who are able to understand and sign the informed consent. (Parent or guardian for minors).
EXCLUSION CRITERIA:
Patients who have been diagnosed with acute and progressive neurological disorders.
Patients who are unable to comply with the study procedures and require other than standard care.

Location and Contact Information


Maryland
      National Institute of Neurological Disorders and Stroke (NINDS), 9000 Rockville Pike,  Bethesda,  Maryland,  20892,  United States; Recruiting
Patient Recruitment and Public Liaison Office  1-800-411-1222    prpl@mail.cc.nih.gov 
TTY  1-866-411-1010 

More Information

Detailed Web Page

Study ID Numbers:  970070; 97-N-0070
Record last reviewed:  November 8, 2004
Last Updated:  February 12, 2005
Record first received:  November 3, 1999
ClinicalTrials.gov Identifier:  NCT00001664
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources